Calcium

More than 99% of the body's calcium sits in bone as a structural mineral. The other 1%, circulating in blood and inside cells, runs an enormous amount of biology: nerve signalling, muscle contraction, blood clotting, hormone release, and gene transcription. That dual role is why calcium intake can't be optimised by simply maximising the number on the label. The skeleton wants enough; the bloodstream and the inside of every cell want it tightly regulated. Get the regulation wrong — usually by taking large isolated supplements — and the same mineral that builds bone starts calcifying arteries and pushing cells toward premature ageing.

The dietary-versus-supplement divide

This is the single most important thing to understand about calcium, and it is counter-intuitive: calcium from food protects the cardiovascular system, while calcium from supplements carries a probable risk signal — at the same total intake.

The protective side is consistent. In large prospective cohorts, higher dietary calcium intake tracks with lower all-cause mortality, lower cardiovascular disease, and fewer strokes, in a J-shaped curve where moderate-to-moderately-high intake is optimal and only extreme intakes reverse the benefit.^[1] The clearest illustration is the Multi-Ethnic Study of Atherosclerosis (MESA), which followed 5,448 adults free of cardiovascular disease for a decade: those with the highest total calcium intake had the lowest risk of developing new coronary artery calcification — the calcified plaque that hardens arteries.^[2]

The supplement side looks different. When the same MESA analysis isolated supplement use — adjusting for total intake — calcium supplements were independently associated with a 22% higher risk of developing coronary artery calcification.^[3] A widely cited meta-analysis of randomized trials found calcium supplements raised coronary heart disease risk by about 20% and myocardial infarction (heart attack) risk by about 21%.^[4] An earlier meta-analysis put the heart-attack signal at about 31%.^[5] And in a community cohort, supplement users who already had a high dietary calcium intake (above 1,400 mg/day) had more than double the all-cause mortality of others.^[6]

The evidence is genuinely contested, and honesty requires saying so. A 2020 umbrella review of randomized trials in almost 90,000 community-dwelling adults found no significant difference in mortality or major cardiovascular events between calcium supplementation and placebo.^[7] The longest hard-outcome readout is the 22-year follow-up of the Women's Health Initiative (WHI) trial (about 36,000 postmenopausal women randomized to 1,000 mg calcium carbonate plus 400 IU vitamin D3 or placebo for roughly seven years): supplementation was tied to a small reduction in cancer mortality (about 7%) but a small increase in cardiovascular mortality (about 6%), with no effect on all-cause mortality — a trade-off that maps almost exactly onto the food-versus-supplement thesis, though the trial cannot separate calcium's effect from vitamin D's (Moderate).^[8] Mendelian-randomization (genetic) studies are split, but not evenly: the most-cited analysis found that a lifelong genetic tendency to higher serum calcium tracks with higher odds of coronary artery disease and heart attack, triangulating the cardiovascular signal.^[9] Notably, the same genetic approach finds no skeletal upside — genetically higher serum calcium is not associated with greater bone density or fewer fractures — and broader reviews of these studies confine the causal effects to the heart, not to bone, stroke, cancer, or diabetes.^[10][11] Industry-aligned reviewers argue the harm trials had compliance and confounding problems. The fair reading is not "supplements are proven dangerous" but "supplements offer no cardiovascular upside and carry a plausible downside that food does not — so the burden of proof is on supplementing, not on eating calcium-rich food."

Why the form matters: the bolus effect

The mechanism that reconciles the divide is pharmacokinetic. Food delivers calcium slowly, bound up in protein, fat, and organic acids, so serum calcium barely moves. A supplement delivers 500–1,000 mg of elemental calcium at once, overwhelming the gut's regulated active-transport pathway and flooding the blood by passive diffusion. A single bolus keeps serum calcium elevated for up to eight hours.^[12]

That transient spike has two near-term effects measured in randomized trials of postmenopausal women: blood pressure rises by more than 5 mmHg versus placebo, and the blood becomes measurably more prone to clotting within four hours of the dose — calcium is a required cofactor at several steps of the clotting cascade.^[13] Repeated daily, these spikes are the plausible bridge between a calcium pill and the slow accumulation of arterial calcification. Food never produces the spike, which is why dietary calcium and supplemental calcium part ways in the outcome data.

The practical corollaries fall straight out of this: never take more than ~500 mg of elemental calcium at once, always take it with a meal, and prefer a slow-release form if you supplement at all.

How much, and where to get it

The recommended intake is 1,000 mg/day for adults 19–50 (and men to 70), rising to 1,200 mg/day for women over 50 and everyone over 70, as absorption efficiency falls with age from roughly 30% in young adults to 15–20% later in life.^[14] The tolerable upper limit is 2,000–2,500 mg/day — but it is nearly impossible to exceed from food alone; calcium toxicity is almost exclusively a supplement phenomenon.

Food sources are not equal, because plant inhibitors (oxalate, phytate) bind calcium in the gut:

The reader-level takeaway: dairy and low-oxalate greens are efficient; spinach is not, regardless of its high label content. A serial National Health and Nutrition Examination Survey (NHANES) analysis (1999–2023) found mean dietary calcium has fallen (about 1,025 → 900 mg/day) while oxalate and phytate intake rose and population bone density dropped in parallel — so the food-first target is harder to hit than it used to be. See Bone density.

Does calcium prevent fractures?

This is the reader's first practical question, and the honest answer depends almost entirely on who you are. In healthy community-dwelling adults, calcium — with or without vitamin D — does not measurably prevent fractures. In the vitamin-D-deficient or institutionalised elderly, it clearly does. That split reconciles a literature that otherwise looks contradictory.

The strongest evidence in the general population is null (Strong). A meta-analysis of 33 randomized trials in more than 51,000 community-dwelling adults over 50 found no significant association of calcium, vitamin D, or the two combined with hip fracture or total fractures — and no benefit in any subgroup defined by dose, sex, fracture history, dietary calcium, or baseline vitamin D level.^[15] A parallel reading of the bone-density data explains why: increasing calcium intake, from food or supplements, raises bone mineral density by only about 1% — a one-time, non-progressive bump the authors judged "unlikely to lead to a clinically significant reduction in fracture risk."^[16]

The exception is real and instructive (Moderate). The trial that founded the whole field enrolled 3,270 institutionalised French women, average age 84, who were mildly calcium-deficient and low in vitamin D at baseline. Giving them 1,200 mg of elemental calcium plus 800 IU of vitamin D3 daily cut hip fractures by 43% and other nonvertebral fractures by 32% over 18 months.^[17] In absolute terms the hip-fracture benefit was on the order of one avoided fracture per hundred women over that period — a genuine but modest effect that appears only because these women started out deficient. Pooled meta-analyses that report a benefit — for example the National Osteoporosis Foundation analysis of eight trials, which found calcium-plus-vitamin-D reduced total fractures by about 15% and hip fractures by about 30% — draw most of that signal from these institutional cohorts, not from healthy free-living adults.^[18]

Guideline bodies have converged on the same population split. The US Preventive Services Task Force recommends against daily supplementation with 400 IU or less of vitamin D plus 1,000 mg or less of calcium for primary fracture prevention in community-dwelling postmenopausal women, and finds the evidence insufficient at higher doses (Moderate).^[19] The practical rule that falls out: routine calcium supplements do not prevent fractures unless you are genuinely deficient or institutionalised — which sharpens, rather than contradicts, the food-first message. For bone, the dominant lever is heavy resistance training, not a calcium pill. See Bone density.

The synergistic triad: vitamin D, vitamin K2, and magnesium

Calcium should never be optimised in isolation. Whether absorbed calcium ends up in bone or in arterial walls is decided by three cofactors.

Vitamin D is the gatekeeper for absorption — it raises calcium uptake from a basal 10–15% to 30–40%, and is required to transcribe osteocalcin, the bone protein that locks calcium into the skeletal matrix. Target a 25-hydroxyvitamin D of 75–125 nmol/L (30–50 ng/mL). See Vitamin D.

Vitamin K2 directs the traffic. Vitamin D builds the calcium-binding proteins, but they are inert until vitamin K2 activates them (by carboxylation). Two matter: osteocalcin pulls calcium into bone, and Matrix Gla Protein sweeps calcium out of arterial walls. In a vitamin-K2-deficient state — common on modern diets — you absorb calcium efficiently but lack the machinery to route it, the setup behind the so-called "double burden" of simultaneous osteoporosis and arterial calcification.^[20] Practical dose: MK-7 at 90–180 µg/day, alongside D3. Coordinate with your prescriber if you take warfarin. See Vitamin K2.

Magnesium is calcium's biochemical counterweight. The two compete for the same gut transporters, so a heavy calcium load suppresses magnesium absorption and pushes the body toward relative magnesium depletion. The dietary calcium-to-magnesium ratio may be a useful risk marker, though the evidence is observational and low-grade rather than settled: an optimum around 2.0–2.8 has been proposed, and ratios above ~3.0 — typically from heavy dairy or calcium supplements without enough magnesium-rich greens, nuts, and seeds — have been associated with higher inflammation (interleukin-6) and worse cardiovascular and mortality outcomes (Weak-preliminary).^[21][22] The corrective is to keep magnesium intake at roughly half of calcium intake. See Magnesium.

Calcium inside the cell: the longevity-specific angle

Beyond bone and arteries, the deepest connection to ageing happens inside cells. Resting cells keep cytosolic calcium extremely low and release it in brief, precise pulses to signal. Loss of that tight control is a recognised feature of cellular ageing.

As cells age, the pumps that clear calcium from the cytosol (the sarco/endoplasmic reticulum and plasma-membrane calcium pumps) lose efficiency, and aged cells take 4–5 times longer to return calcium to baseline after a stimulus — a prolonged, toxic elevation. Senescent cells also leak calcium continuously from the endoplasmic reticulum; experimentally knocking down the leak channels lets cells escape senescence, which puts calcium leak close to a master switch in the ageing cascade.^[23] Oxidative stress amplifies the damage: it drives calcium transients that trigger the DNA-damage response and lock cells into senescence, while chelating intracellular calcium protects them and stimulates autophagy.^[24]

This connects to mitochondria. A modest, regulated flow of calcium into mitochondria (via the mitochondrial calcium uniporter, MCU) is needed to drive energy production — but overload opens the permeability transition pore and triggers cell death. The longevity protein SIRT1 helps gate this; as it declines with age, the gate is left open. Intriguingly, in nematode (C. elegans) lifespan models, slightly restricting calcium entry into mitochondria extends lifespan and preserves late-life mobility — a form of mitohormesis, where mild mitochondrial stress provokes a durable protective response.^[25][26]

These are mechanistic and largely preclinical findings, not a basis for any intervention. The honest reading: they explain why whole-body calcium overload is plausibly harmful at the cellular level, and they reinforce that the body's goal for calcium is precise regulation, not maximal quantity. The actionable levers that touch this biology are the ones already on the longevity list — exercise (which raises mitochondrial quality through the same hormetic pathway), not a calcium product.

Two clinical signals worth knowing

Dementia (Weak-preliminary). One small five-year observational study of women aged 70–92 suggested that those taking calcium supplements had roughly double the rate of incident dementia, rising several-fold in the subset with prior cerebrovascular damage — a history of stroke or white-matter lesions on brain imaging.^[27] The subtype most strongly linked was vascular dementia, consistent with the same coagulation-and-calcification mechanism that drives the cardiovascular signal. But this rested on fewer than a hundred supplement users with wide confidence intervals, so it is hypothesis-generating rather than established — a reason for caution specifically in older women with existing vascular disease, not a general alarm.

Parathyroid hormone (PTH) as a biomarker. When calcium and vitamin D status is chronically inadequate, the parathyroid glands raise PTH to pull calcium from bone — and chronically elevated PTH is an independent predictor of cardiovascular and all-cause mortality across large cohorts and meta-analyses.^[28] Among Chinese centenarians, the combination of low vitamin D, high PTH, and a high bone-resorption marker carried nearly triple the mortality risk.^[29] The lesson is not to chase PTH down with supplements, but that correcting genuine vitamin D and dietary calcium deficiency — which suppresses PTH into the normal range — is the validated win.

Calcium and cancer: a mixed ledger

The cancer evidence cuts both ways, which is worth knowing on a longevity page.

On the protective side, calcium supplements modestly reduce recurrence of colorectal adenomas — the polyps that precede colorectal cancer. A meta-analysis of randomized trials found about a 13% lower recurrence rate, roughly one avoided recurrence for every 20 people supplemented over three to five years, though the effect on the more dangerous advanced adenomas was not significant (Moderate).^[30] This is consistent with the cancer-mortality reduction seen in the long-term WHI follow-up above.

On the caution side, higher calcium intake carries a small signal for prostate cancer in men. A large meta-analysis of cohort studies found that each additional 400 mg/day of dietary calcium was associated with about a 5% higher risk of total prostate cancer, and supplemental calcium specifically was linked to a higher risk of fatal prostate cancer (Weak-preliminary).^[31] The evidence is graded limited-suggestive rather than conclusive, but it is a reason for men in particular not to push total calcium far above the requirement with supplements.

The kidney-stone paradox

For decades, calcium-stone formers were told to restrict dietary calcium. That was backwards. Adequate dietary calcium binds oxalate in the gut, forming an insoluble complex that leaves in the stool instead of being absorbed and concentrated in the urine — so higher dietary calcium is protective against the most common (calcium-oxalate) stones.^[32]

The critical variable is timing relative to food. Calcium taken with meals lowers urinary oxalate and stone-formation risk. The same calcium taken between meals or at bedtime — with no dietary oxalate to bind — is simply absorbed, raising urinary calcium while unbound oxalate from earlier meals is absorbed too, creating exactly the supersaturated urine that crystallises stones. This is the strongest single argument for the rule that any calcium supplement must be taken with food. The supporting randomized evidence is direct: in the Women's Health Initiative trial, calcium-plus-vitamin-D supplements raised urinary-tract stones by about 17% versus placebo — a result that reinforces, rather than undercuts, the food-first and with-meals rules (Moderate).^[33]

If you must supplement: choosing a form

Supplements should bridge a documented dietary gap, not act as the primary source. If you supplement, the form changes both absorption and side effects:

Calcium citrate is the sensible default for general use — a meta-analysis of 15 absorption studies found it is absorbed about 22–27% better than carbonate, both on an empty stomach and with meals,^[34] and unlike carbonate it does not need gastric acid, which is why it is the right choice for older adults and anyone on a proton-pump inhibitor.^[35] Microcrystalline hydroxyapatite is the form most aligned with the bolus-effect logic, since its slow, sustained serum profile avoids the spike while still suppressing bone turnover.^[36][37] The headline bioavailability claims for calcium lysinate come from a single industry trial and shouldn't be over-weighted.^[38]

A practical calcium protocol

1. Target 1,000–1,200 mg/day, food first. Dairy and low-oxalate greens (kale, broccoli, bok choy), calcium-set tofu, and bone-in fish. Don't count spinach.
2. Supplement only the gap. Estimate dietary intake; supplement the shortfall, not a flat 1,000 mg on top.
3. Never bolus. Cap any single dose at ~500 mg of elemental calcium and split larger needs across the day.
4. Always with a meal. It blunts the serum spike and binds dietary oxalate, neutralising the kidney-stone risk.
5. Take the triad. Vitamin D3 to a 25(OH)D of 75–125 nmol/L (30–50 ng/mL), vitamin K2 (MK-7) 90–180 µg/day, and enough magnesium to keep the dietary Ca:Mg ratio near 2–2.8.
6. Prefer citrate, or hydroxyapatite if you want the slowest serum profile.
7. For bone, calcium is necessary but not sufficient — the dominant osteogenic stimulus is heavy resistance training. See Bone density.
8. Be especially cautious with supplements if you're an older woman with existing vascular disease — that's where both the dementia and cardiovascular signals concentrate. Work with a clinician.

What's overrated

• "More calcium means stronger bones." Above the requirement, extra calcium doesn't add bone — and as a supplement it adds cardiovascular and stone risk. The dose-response flattens; the harm doesn't.
• High-dose calcium monotherapy. A large pill of calcium alone, without vitamin D, K2, and magnesium, is the single configuration the evidence most clearly cautions against.
• Restricting dietary calcium to prevent stones. Backwards — adequate dietary calcium taken with meals is protective.
• Spinach as a calcium source. Oxalate binds almost all of it.
• Coral, oyster-shell, and "whole-food" calcium marketing. No demonstrated advantage over plain citrate, and shell-derived products carry occasional heavy-metal concerns.

For the broader picture of which supplements help, which are gap-fillers, and which cause harm, see Supplements and Supplements to avoid.

Further reading

• Anderson JJB et al. Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification: 10-Year Follow-up of MESA. J Am Heart Assoc 2016.^[39]
• Yang C et al. The Evidence and Controversy Between Dietary Calcium Intake and Calcium Supplementation and the Risk of Cardiovascular Disease — systematic review and meta-analysis. J Am Coll Nutr 2019.^[40]
• Bolland MJ et al. Effect of calcium supplements on risk of myocardial infarction — meta-analysis. BMJ 2010.^[41]
• Michaëlsson K et al. Long-term calcium intake and rates of all-cause and cardiovascular mortality. BMJ 2013.^[42]
• Zhao J-G et al. Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults. JAMA 2017.^[43]
• Chapuy MC et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992.^[44]
• Thomson CA et al. Long-Term Effect of Randomization to Calcium and Vitamin D Supplementation on Health in Older Women. Ann Intern Med 2024.^[45]
• Larsson SC et al. Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction. JAMA 2017.^[46]
• Bonovas S et al. Calcium supplementation for the prevention of colorectal adenomas — meta-analysis of randomized controlled trials. World J Gastroenterol 2016.^[47]
• Bristow SM et al. Acute effects of calcium supplements on blood pressure and blood coagulation: secondary analysis of a randomised controlled trial in post-menopausal women. Br J Nutr 2015.^[48]
• van Ballegooijen AJ et al. The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health. 2017.^[49]
• Hibler EA et al. Physical activity, dietary calcium to magnesium intake and mortality in the National Health and Examination Survey 1999-2006 cohort. Int J Cancer 2020.^[50]
• Kern J et al. Calcium supplementation and risk of dementia in women with cerebrovascular disease. Neurology 2016.^[51]
• Late-life survival and mobility via mitohormesis by reducing mitochondrial calcium. 2025.^[52]
• Calcium and vitamin D supplementation and kidney stone disease — narrative review. 2021.^[53]
• Sakhaee K et al. Meta-analysis of calcium bioavailability: a comparison of calcium citrate with calcium carbonate. Am J Ther 1999.^[54]
• Recker RR. Calcium absorption and achlorhydria. N Engl J Med 1985.^[55]
• NIH Office of Dietary Supplements. Calcium — Health Professional Fact Sheet.^[56]

---